Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,322,943
+$96,580 QoQ
Shares Held
13,084
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#1,928
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bedel Financial Consulting, Inc. holds $404,013,991 across 11 Drug Manufacturers - General names. JNJ ranks #2 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
328,198 | $393,650,559 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
13,084 | $3,322,943 | |
| 3 | ABBV |
AbbVie Inc.
|
11,757 | $2,958,531 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,015 | $901,427 | |
| 5 | PFE |
Pfizer Inc
|
31,588 | $760,639 | |
| 6 | NVS |
Novartis AG
|
4,326 | $677,970 | |
| 7 | AMGN |
Amgen Inc
|
1,648 | $596,773 | |
| 8 | GSK |
GSK plc
|
7,562 | $396,400 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,322,943 | 13,084 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,226,363 | 13,199 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,752,021 | 13,298 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,635,189 | 14,212 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,119,864 | 13,878 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,446,305 | 14,751 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,151,656 | 14,878 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,253,444 | 13,905 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,068,602 | 14,153 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,289,958 | 14,476 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,266,773 | 14,462 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,327,839 | 14,946 | Shares | Sole | 2024-02-08 | |
| 2023-06-30 | $2,461,778 | 14,873 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,297,255 | 14,821 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,579,443 | 14,602 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,348,953 | 14,379 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,547,623 | 14,352 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,418,126 | 13,644 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $2,301,746 | 13,455 | Shares | Other | 2022-01-11 | |
| 2021-09-30 | $2,399,728 | 14,859 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,441,611 | 14,821 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,352,177 | 14,312 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,688,372 | 10,728 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,596,886 | 10,726 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,511,631 | 10,749 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $1,517,042 | 11,569 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||